Author

Dong Moon Shin

Frances Kelly Blomeyer Distinguished Chair in Cancer Research, Professor of Hematology and Medical - Cited by 66,589 - Hematology - Medical Oncology

Biography

Dr. Dong Moon Shin  is currently working in Department of Hematology and Medical Oncology, The Winship Cancer institute of Emory University, Atlanta, Georgia, USA. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Title
Cited by
Year
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer
CS Eberhardt, HT Kissick, MR Patel, MA Cardenas, N Prokhnevska, ...Nature 597 (7875), 279-284, 2021202
107
2021
Gut microbiome associated with the psychoneurological symptom cluster in patients with head and neck cancers
J Bai, DW Bruner, V Fedirko, JJ Beitler, C Zhou, J Gu, H Zhao, IH Lin, ...Cancers 12 (9), 2531, 2020202
26
2020
The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms
C Xiao, V Fedirko, J Beitler, J Bai, G Peng, C Zhou, J Gu, H Zhao, IH Lin, ...Supportive Care in Cancer 29, 3173-3182, 2021202
22
2021
Small cell and squamous cell carcinomas of the head and neck: comparing incidence and survival trends based on Surveillance, Epidemiology, and End Results (SEER) Data
MB Bean, Y Liu, R Jiang, CE Steuer, M Patel, MW McDonald, KA Higgins, ...The Oncologist 24 (12), 1562-1569, 2019201
22
2019
Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1
C Pan, JH Kang, JS Hwang, J Li, AC Boese, X Wang, L Yang, TJ Boggon, ...Nature communications 12 (1), 4960, 212
20
2021
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: a longitudinal study
C Xiao, JJ Beitler, G Peng, ME Levine, KN Conneely, H Zhao, JC Felger, ...Cancer 127 (18), 3361-3371, 212
20
2021
Phase II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and/or metastatic head and neck squamous cell carcinoma
CH Chung, J Li, CE Steuer, P Bhateja, M Johnson, J Masannat, MI Poole, ...Clinical Cancer Research 28 (11), 2329-2338, 2022202
17
2022
Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models
ARM Amin, D Wang, S Nannapaneni, R Lamichhane, ZG Chen, DM ShinOncology Reports 45 (5), 1-10, 2021202
16
2021
Parenteral bevacizumab for the treatment of severe respiratory papillomatosis in an adult population
A Tkaczuk, S Trivedi, MD Mody, CE Steuer, DM Shin, AM Klein, NF SabaThe Laryngoscope 131 (3), E921-E928, 2021202
15
2021
Tumor membrane vesicle vaccine augments the efficacy of anti-PD1 antibody in immune checkpoint inhibitor-resistant squamous cell carcinoma models of head and neck cancer
R Bommireddy, LE Munoz, A Kumari, L Huang, Y Fan, L Monterroza, ...Vaccines 8 (2), 182, 2020202
14
2020
Combinatorial approaches targeting the EGFR family and c-Met in SCCHN
D Wang, Y Lu, S Nannapaneni, CC Griffith, C Steuer, G Qian, X Wang, ...Oral oncology 112, 105074, 2021202
14
2021
Phase Ib study of chemoprevention with green tea polyphenon E and erlotinib in patients with advanced premalignant lesions (APL) of the head and neck
DM Shin, S Nannapaneni, MR Patel, Q Shi, Y Liu, Z Chen, AY Chen, ...Clinical Cancer Research 26 (22), 5860-5868, 2020202
12
2020
Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer
C Xiao, AH Miller, G Peng, ME Levine, KN Conneely, H Zhao, ...International Journal of Radiation Oncology* Biology* Physics 111 (1), 157-167, 2021202
9
2021
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local‐regional failures
VR Dhere, CE Escott, S Tian, JM Switchenko, JP Bell, WA Stokes, ...Head & Neck 44 (2), 32-390, 2022202
8
2022
A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).
NF Saba, A Ekpenyong, A McCook-Veal, M Patel, NC Schmitt, WA Stokes, ...Journal of Clinical Oncology 40 (16_suppl), 600-600, 2022202
8
2022
Socioeconomic factors influence the impact of tumor HPV status on outcome of patients with oropharyngeal squamous cell carcinoma
JA Marks, JM Switchenko, CE Steuer, M Ryan, MR Patel, MW McDonald, ...JCO Oncology Practice 17 (3), e313-e322, 2021202
8
2021
Demographic and Socioeconomic Factors Associated With Metastases at Presentation in HPV–Related Squamous Cell Carcinoma of the Head and Neck: An NCDB Analysis
MB Bean, JM Switchenko, CE Steuer, M Patel, K Higgins, M McDonald, ...JCO Oncology Practice 16 (6), e46-e48, 2020202
7
2020
Association among glucocorticoid receptor sensitivity, fatigue, and inflammation in patients with head and neck cancer
C Xiao, RC Eldridge, JJ Beitler, KA Higgins, CE Chico, JC Felger, ...Psychosomatic medicine 82 (5), 508, 2020202
7
2020
Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma
S Nannapaneni, CC Griffith, KR Magliocca, W Chen, X Lyu, Z Chen, ...Plos one 16 (2), e024498, 2021202
7
2021
Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population––A SEER‐based analysis from 2000 to 2016
MA Taylor, J Switchenko, W Stokes, MR Patel, M McDonald, C Steuer, ...Cancer Medicine 10 (17), 6070-6077, 2021202
5
2021

Referred From: https://scholar.google.com/citations?hl=en&user=VIT_03oAAAAJ

Cited by
Citations 66589
h-index 98
i10-index 278
Recommended Journals
Open Access Journals